Detalhe da pesquisa
1.
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier.
Acta Neuropathol
; 129(1): 39-52, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25388784
2.
C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
Acta Neuropathol
; 128(4): 525-41, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24806409
3.
CNS myelination requires VAMP2/3-mediated membrane expansion in oligodendrocytes.
Nat Commun
; 13(1): 5583, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151203
4.
Cross-Comparison of Human iPSC Motor Neuron Models of Familial and Sporadic ALS Reveals Early and Convergent Transcriptomic Disease Signatures.
Cell Syst
; 12(2): 159-175.e9, 2021 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33382996
5.
Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72.
Brain Res
; 1728: 146601, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843624
6.
C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD.
Neuron
; 88(5): 892-901, 2015 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637796